Cointime

  • 快讯
  • 头条
  • 行情
  • 专栏
  • 活动
  • 比特币 ¥747,994.59 -2.13%
  • 以太坊 ¥18,003.23 -2.09%
  • 币安币 ¥4,639.27 -0.57%
  • Optimism ¥4.02 -3.75%
  • Arbitrum ¥2.17 -4.75%
  • Solana ¥1,050.11 -2.24%
  • Polygon ¥1.56 +2.77%
  • Cosmos ¥28.74 -2.94%
  • Avalanche ¥132.91 -2.53%
  • 比特币 ¥747,994.59 -2.13%
  • 以太坊 ¥18,003.23 -2.09%
  • 币安币 ¥4,639.27 -0.57%
  • Optimism ¥4.02 -3.75%
  • Arbitrum ¥2.17 -4.75%
  • Solana ¥1,050.11 -2.24%
  • Polygon ¥1.56 +2.77%
  • Cosmos ¥28.74 -2.94%
  • Avalanche ¥132.91 -2.53%
Home / Blueprint Medicines / investors

Blueprint Medicines

company

Investors

Number of Lead Investors
Number of Investors
4
15
Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Partner Fund Management Yes Series C
Eight Roads Ventures Yes Series Unknown
Casdin Capital - Series C
Cowen Group - Series C
Fidelity Biosciences - Series C
Nextech Invest - Series C
Perceptive Advisors - Series C
RA Capital Management - Series C
Redmile Group - Series C
Sabby Capital - Series C
Tavistock Life Sciences - Series C
Third Rock Ventures - Series C
Wellington Management - Series C
Biotechnology Value Fund - Series B
F-Prime Capital - Series B

Contact

Cambridge,Massachusetts,United States
617-374-7580
Cointime
头条
  • 即时新闻
  • 全球政策
  • 比特币
  • 以太坊
  • 狗狗币
  • 区块链
  • 元宇宙
  • 区块链游戏
  • Web3
  • DeFi
  • NFT
热点
  • 项目报道
  • 行业洞见
  • 新闻
  • 教程
  • 政策解读
  • 专题
  • 专栏
  • 行情
  • 活动
  • 标签
RSS
  • 即时新闻
  • 头条
公司
  • 关于我们
  • 广告合作
  • 免责声明
  • © 2023 Cointime. 版权所有
  • 隐私政策
  • 服务条款